Technology | March 12, 2014

Toshiba’s CT Myocardial Perfusion Helps Produce Faster, Safer Cardiac Diagnoses

Solution allows clinicians to visualize myocardial ischemia with CT

Toshiba CT Myocardial Perfusion Advanced Visualization CT Systems

 

March 12, 2014 — The U.S. Food and Drug Administration (FDA) cleared Toshiba’s CT Myocardial Perfusion capability. Available on Toshiba’s Aquilion One and Aquilion OneVison Edition CT systems, Myocardial Perfusion allows clinicians to visualize myocardial ischemia with CT, providing a clinical and operational solution to make work flow.

The Myocardial Perfusion on Toshiba’s 320-detector-row CTs shows blood flow and anatomy within the coronary arteries to help determine the viability of the heart muscle. This enables clinicians to make faster and more accurate decisions on whether to undergo revascularization of coronary blockages. Toshiba’s CT Myocardial Perfusion puts patient experience first with shorter exam times and significantly lower radiation exposure.

Toshiba will showcase its Myocardial Perfusion technology at the American College of Cardiology (ACC) annual meeting in Washington, D.C., March 29–April 2 (Booth #2323).

For more information: www.medical.toshiba.com

Related Content

Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
3D Systems Announces On Demand Anatomical Modeling Service
Technology | Medical 3-D Printing | June 18, 2018
3D Systems announced availability of its new On Demand Anatomical Modeling Service. This new service provides a wide...
Weight-Bearing CT International Study Group Hosts  Scientific Session at AOFAS Conference
News | Computed Tomography (CT) | June 15, 2018
June 15, 2018 —The Weight-Bearing CT International Study Group will host a scientific session on the benefits of weig
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
360 Photos | 360 View Photos | June 14, 2018
This is a 360 degree image from the Canon Aquilion 64-slice...
Technology | Orthopedic Imaging | June 13, 2018
EOS imaging announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its hipEOS...
American Society of Neuroradiology Honors Peter Chang with Cornelius G. Dyke Memorial Award
News | Neuro Imaging | June 13, 2018
Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for...
Reduced hippocampal volume on MRI

This figure shows reduced hippocampal volume over the course of 6 years as seen on progressive volumetric analysis and also coronal MRI evaluations (arrows).Progressive volume loss in the mesial temporal lobe on MRI is a characteristic imaging feature of AD. This patient was a case of Alzheimer’s Dementia.

 

News | Neuro Imaging | June 12, 2018
According to a UCLA Medical Center study, a new technology shows the potential to help doctors better determine when...
NewYork-Presbyterian Expands Mobile Stroke Treatment Unit Fleet

Image courtesy of NewYork-Presbyterian Hospital

News | Stroke | June 11, 2018
NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the...
Overlay Init